Saphenous vein graft overview: Difference between revisions
(Created page with "{{Infobox_Disease | Name = {{PAGENAME}} | Image = Heart saphenous coronary grafts.jpg|| Caption = Saphenous vein grafts for coronary arteries| ...") |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 25: | Line 25: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 15:52, 20 August 2012
| Saphenous vein graft overview | |
 | |
|---|---|
| Saphenous vein grafts for coronary arteries |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Jason C. Choi, M.D.; Xin Yang, M.D.
Overview
Since Rene Favaloro first described it in 1967, coronary artery revascularization with saphenous veins (saphenous vein grafts or SVGs) has become a surgical standard for treatment of coronary artery disease. When a native coronary artery is obstructed, the sutured graft provides a connection between the aorta and the coronary artery beyond the area of obstruction. The procedure is repeated on all the coronary artery segments that are significantly diseased.
The vein is often removed by cardiac surgeons and used for autotransplantation in coronary artery bypass operations, when arterial grafts are not available or many grafts are required, such as in a triple bypass or quadruple bypass.